Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Clinical Research and Equipment Industry Analysis

UpdatedJun 15, 2025
DataAggregated Company Financials
Companies7
  • 7D-0.9%
  • 3M1.3%
  • 1Y3.5%
  • YTDn/a

The Clinical Research and Equipment industry has stayed flat over the last week. As for the the longer term, the industry is up 3.5% over the past 12 months. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Swiss Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 16 Jun 2025CHF 52.9bCHF 10.1bCHF 1.0b32.5x51x5.2x
Wed, 14 May 2025CHF 53.1bCHF 10.1bCHF 1.0b32.6x51.2x5.3x
Fri, 11 Apr 2025CHF 47.7bCHF 10.1bCHF 1.0b27.6x46.4x4.7x
Sun, 09 Mar 2025CHF 53.9bCHF 10.1bCHF 1.0b30.1x51.6x5.3x
Tue, 04 Feb 2025CHF 56.6bCHF 10.1bCHF 1.0b36.1x56.2x5.6x
Thu, 02 Jan 2025CHF 52.7bCHF 10.2bCHF 943.4m35.5x55.8x5.2x
Sat, 30 Nov 2024CHF 53.4bCHF 10.2bCHF 943.7m41x56.6x5.2x
Mon, 28 Oct 2024CHF 56.0bCHF 10.2bCHF 943.5m42x59.4x5.5x
Wed, 25 Sep 2024CHF 55.1bCHF 10.2bCHF 943.3m42.2x58.4x5.4x
Fri, 23 Aug 2024CHF 58.4bCHF 10.2bCHF 920.7m48.2x63.4x5.7x
Sun, 21 Jul 2024CHF 54.0bCHF 10.3bCHF 1.0b46.8x53.9x5.3x
Tue, 18 Jun 2024CHF 50.9bCHF 10.3bCHF 1.0b43.7x50.8x5x
Thu, 16 May 2024CHF 56.3bCHF 10.3bCHF 1.0b46.2x56.2x5.5x
Sat, 13 Apr 2024CHF 55.8bCHF 10.3bCHF 1.0b43.9x55.7x5.4x
Mon, 11 Mar 2024CHF 51.9bCHF 10.2bCHF 995.4m48.1x52.1x5.1x
Wed, 07 Feb 2024CHF 48.0bCHF 10.2bCHF 1.0b41.5x47.1x4.7x
Fri, 05 Jan 2024CHF 41.0bCHF 9.8bCHF 1.5b31.1x27.4x4.2x
Sun, 03 Dec 2023CHF 39.6bCHF 9.8bCHF 1.5b29.4x26.5x4.1x
Tue, 31 Oct 2023CHF 36.4bCHF 9.8bCHF 1.5b25.3x24.4x3.7x
Thu, 28 Sep 2023CHF 45.9bCHF 9.8bCHF 1.5b31.5x30.8x4.7x
Sat, 26 Aug 2023CHF 51.9bCHF 9.8bCHF 1.5b36x34.8x5.3x
Mon, 24 Jul 2023CHF 52.2bCHF 9.8bCHF 1.5b36.1x33.7x5.3x
Wed, 21 Jun 2023CHF 55.6bCHF 9.7bCHF 1.6b35.3x34.1x5.7x
Fri, 19 May 2023CHF 59.4bCHF 9.7bCHF 1.6b38.1x36.4x6.1x
Sun, 16 Apr 2023CHF 61.4bCHF 9.7bCHF 1.7b42.3x36.8x6.3x
Tue, 14 Mar 2023CHF 55.0bCHF 9.6bCHF 1.7b32.1x33.1x5.7x
Thu, 09 Feb 2023CHF 58.6bCHF 9.6bCHF 1.6b34x35.8x6.1x
Sat, 07 Jan 2023CHF 50.3bCHF 9.2bCHF 1.3b37.4x37.9x5.5x
Mon, 05 Dec 2022CHF 54.6bCHF 9.2bCHF 1.3b41.1x41.1x5.9x
Wed, 02 Nov 2022CHF 51.0bCHF 9.2bCHF 1.3b39.9x38.3x5.6x
Fri, 30 Sep 2022CHF 48.4bCHF 9.2bCHF 1.3b38.2x37.5x5.3x
Sun, 28 Aug 2022CHF 55.3bCHF 9.1bCHF 1.3b43.9x43.9x6.1x
Tue, 26 Jul 2022CHF 54.5bCHF 8.9bCHF 1.3b34.6x41.5x6.1x
Thu, 23 Jun 2022CHF 51.2bCHF 8.5bCHF 1.1b44x47.5x6x
Price to Earnings Ratio

47.5x


Total Market Cap: CHF 51.2bTotal Earnings: CHF 1.1bTotal Revenue: CHF 8.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Clinical Research and Equipment Industry Price to Earnings3Y Average 44.7x202320242025
Current Industry PE
  • Investors are optimistic on the Swiss Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 51.0x which is higher than its 3-year average PE of 44.7x.
  • The industry is trading close to its 3-year average PS ratio of 5.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Swiss Clinical Research and Equipment compare with similar industries?

CH Market-1.57%
Healthcare-0.31%
Life Sciences-0.86%
Clinical Research and Equipment-0.86%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TECN Tecan GroupCHF 165.901.3%
+CHF 26.7m		-48.7%PE31.2x
BANB Bachem HoldingCHF 54.250.6%
+CHF 22.5m		-31.5%PE33.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SFZN

CHF 94.20

Siegfried Holding

7D

-3.0%

1Y

0.9%

A Look At The Fair Value Of Siegfried Holding AG (VTX:SFZN)

Jun 14
A Look At The Fair Value Of Siegfried Holding AG (VTX:SFZN)

XLS

CHF 19.50

Xlife Sciences

7D

-1.3%

1Y

-39.4%

TECN

CHF 165.90

Tecan Group

7D

1.3%

1Y

-48.7%

LONN

CHF 568.80

Lonza Group

7D

-0.8%

1Y

18.4%

Lonza Group AG (VTX:LONN) Not Flying Under The Radar

May 31
Lonza Group AG (VTX:LONN) Not Flying Under The Radar

SKAN

CHF 74.00

SKAN Group

7D

-1.5%

1Y

-8.1%

PPGN

CHF 20.40

PolyPeptide Group

7D

-4.7%

1Y

-37.9%

Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

May 23
Does PolyPeptide Group (VTX:PPGN) Have A Healthy Balance Sheet?

BANB

CHF 54.25

Bachem Holding

7D

0.6%

1Y

-31.5%

Bachem Holding AG's (VTX:BANB) Share Price Matching Investor Opinion

May 15
Bachem Holding AG's (VTX:BANB) Share Price Matching Investor Opinion